Total Funding
58
53
Total FundingPost-IPO Equity raised
Growth Score 58 in past quarter
-3 pts
Heat Score 53 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
124386
Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.
- Jeff Hackman: President & CEO
David Soane: FounderPast Role: Soane Energy, Founder
About the Company
Comera Life Sciences is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient
to produce.
